Evotec SE (EVOTF) Income from Continuing Operations (2020 - 2025)

Evotec SE's (EVOTF) quarterly Income from Continuing Operations came in at 100864102.82 in Q4 2025, up 51.3% year-on-year from 66667101.08 in Q4 2024, and down 200734.07% quarter-over-quarter from 50222.61 in Q3 2025.

Evotec SE (EVOTF) Income from Continuing Operations (2020 - 2025) Analysis & Trends

Evotec SE has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 100864102.82 for Q4 2025.

  • Income from Continuing Operations for Q4 2025 came in at 100864102.82, up 51.3% year-over-year; the trailing twelve-month figure through Dec 2025 was 308058404.71 (down 3.6% YoY), and the FY2025 annual result was 120498292.51, up 42.49% from the prior year.
  • Income from Continuing Operations came in at 100864102.82 for Q4 2025 at Evotec SE, down from 50222.61 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 246254632.58 in Q4 2021 to a low of 207092601.34 in Q4 2024.
  • The 5-year median for Income from Continuing Operations is 22254.35 (2023), against an average of 22075629.67.
  • Across the five-year window, Income from Continuing Operations jumped 9714.16% in 2021 and tumbled 326.51% in 2024, its largest moves.
  • Evotec SE's Income from Continuing Operations stood at 246254632.58 in 2021, then tumbled by 172.83% to 179338481.97 in 2022, then soared by 49.68% to 90236548.48 in 2023, then slumped by 129.5% to 207092601.34 in 2024, then surged by 51.3% to 100864102.82 in 2025.
  • The last three Income from Continuing Operations figures came in at 100864102.82 (Q4 2025), 50222.61 (Q3 2025), and 207092601.34 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Evotec SE - - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -100.86 Mn
Sep 30, 2025 -50,222.61
Dec 31, 2024 -207.09 Mn
Sep 30, 2024 -51,477.94
Dec 31, 2023 -90.24 Mn
Sep 30, 2023 22,726.50
Jun 30, 2023 -22,254.35
Dec 31, 2022 -179.34 Mn
Sep 30, 2022 39,779.45
Jun 30, 2022 -22,125.42
Mar 31, 2022 -72,868.90
Dec 31, 2021 246.25 Mn
Sep 30, 2021 158,344.09
Jun 30, 2021 72,202.09
Mar 31, 2021 68,554.02
Dec 31, 2020 7.48 Mn
Sep 30, 2020 -1,646.99